David, D J <br/><br/>
Efficacy of the MCHR1 antagonist N-[3-(1-(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Apr 2007 
 - 237-48 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Standard No.: </label>10.1124/jpet.106.109678  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Anxiety Agents<br/>Antidepressive Agents<br/>Antidepressive Agents, Tricyclic--metabolism<br/>Antimetabolites<br/>Anxiety--drug therapy<br/>Bromodeoxyuridine<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Citalopram--metabolism<br/>Drug Evaluation, Preclinical<br/>Feeding Behavior--drug effects<br/>Hippocampus--cytology<br/>Imipramine--metabolism<br/>Immunohistochemistry<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Motor Activity--drug effects<br/>Neurons--drug effects<br/>Piperidines--pharmacology<br/>Receptors, Somatostatin--antagonists & inhibitors<br/>Selective Serotonin Reuptake Inhibitors--metabolism<br/>X-Rays